Juliette Cubanski, PhD, Addresses Challenges Medicare Will Face Moving Forward

The Orphan Drug Act in the Modern Drug Pricing Era

OCEANIC-STROKE trial data show asundexian cuts ischemic stroke across subtypes with no rise in major bleeding, which could reshape antithrombotic choices.

February 3rd 2026

Rethinking Prior Authorization: Bridging Clinical Needs and Administrative Burdens

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

This article highlights challenges in prior authorization and offers practical, experience-based strategies to streamline workflows, reduce delays, and improve patient access to necessary treatments.

January 27th 2026

Scaling Innovation in Advanced Multiple Myeloma Care Delivery: A Q&A With Ameet Patel, MD

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Skin Cancer Risk Extends Beyond Fair Skin, With Persistent Early Detection Disparities: Vishal A. Patel, MD

Ameet Patel, MD, discusses scaling CAR T-cell therapy and bispecific therapies to improve access and potentially cure multiple myeloma.

AJMC Q&A with Dr Vishal Patel | Image Credit: GW Medical Faculty Associates

Asundexian Cuts Recurrent Stroke Risk Without More Bleeding: Mukul Sharma, MD, MSc

Vishal A. Patel, MD, explains that delayed skin cancer diagnoses contribute to more advanced disease and poorer outcomes in patients with darker skin.

Related Content

The Orphan Drug Act in the Modern Drug Pricing Era

OCEANIC-STROKE trial data show asundexian cuts ischemic stroke across subtypes with no rise in major bleeding, which could reshape antithrombotic choices.

February 3rd 2026

Rethinking Prior Authorization: Bridging Clinical Needs and Administrative Burdens

Policy strategist Kristi Martin discusses how the Orphan Drug Act reshapes rare disease treatment and drug-pricing challenges.

Listen

Reflecting on 15 Years of Health IT Evolution and What’s Next: Nate C. Apathy, PhD

This article highlights challenges in prior authorization and offers practical, experience-based strategies to streamline workflows, reduce delays, and improve patient access to necessary treatments.

January 27th 2026

Scaling Innovation in Advanced Multiple Myeloma Care Delivery: A Q&A With Ameet Patel, MD

Nate C. Apathy, PhD, guest editor of AJMC's 15th Health IT special issue, calls for tools to be closely aligned with user needs.

Listen

Skin Cancer Risk Extends Beyond Fair Skin, With Persistent Early Detection Disparities: Vishal A. Patel, MD

Ameet Patel, MD, discusses scaling CAR T-cell therapy and bispecific therapies to improve access and potentially cure multiple myeloma.